673485-37-5

Upstream product

• 633314-23-5 (2-{[2,6-bis-(tert-butyl-dimethyl-silanyloxymethyl)-4-methyl-phenoxycarbonyl]-methyl-amino}-ethyl)-methyl-carbamic acid tert-butyl ester 
• 633314-22-4 2,6-bis(((tert-butyldimethylsilyl)oxy)methyl)-4-methylphenyl (4-nitrophenyl) carbonate 
• 633314-24-6 {2-[(2,6-bis-hydroxymethyl-4-methyl-phenoxycarbonyl)-methyl-amino]-ethyl}-methyl-carbamic acid tert-butyl ester 
• 633314-21-3 2,6-bis(((tert-butyldimethylsilyl)oxy)methyl)-4-methylphenol 
• 530-56-3 syringic alcohol 
• 91-04-3 2,6-bis(hydroxymethyl)-4-methylphenol 
• 7693-46-1 4-Nitrophenyl chloroformate 
• 673485-36-4 [2-({4-[({2-[(2,6-bis-hydroxymethyl-4-methyl-phenoxycarbonyl)-methyl-amino]-ethyl}-methyl-carbamoyloxy)-methyl]-2,6-dimethoxy-phenoxycarbonyl}-methyl-amino)-ethyl]-methyl-carbamic acid 3-hydroxy-3-methyl-5-oxo-hexyl ester 

Relevant academic research and scientific papers

Bioactivation of Self-Immolative Dendritic Prodrugs by Catalytic Antibody 38C2

Self-immolative dendrimers have recently been developed and introduced as a potential platform for a multi-prodrug. These unique structural dendrimers can release all of their tail units, through a self-immolative chain fragmentation, which is initiated b